B
BRLI

Baird’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Baird’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$376K Sell
10,671
-244
-2% -$8.26K ﹤0.01% 1041
2014
Q4 		$351K Sell
10,915
-612
-5% -$17.7K ﹤0.01% 1052
2014
Q3 		$323K Sell
11,527
-7,891
-41% -$240K ﹤0.01% 962
2014
Q2 		$587K Sell
19,418
-10,198
-34% -$281K 0.01% 801
2014
Q1 		$820K Buy
29,616
+12,473
+73% +$326K 0.01% 691
2013
Q4 		$438K Buy
17,143
+442
+3% +$13.6K 0.01% 883
2013
Q3 		$499K Sell
16,701
-294
-2% -$8.18K 0.01% 796
2013
Q2 		$489K Buy
+16,995
New +$468K 0.01% 769

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baird's BRLI Position: Q1 2015 in Review

Baird reduced its BIO-REFERENCE LABS INC-NEW- (BRLI) stake by 2.2% in Q1 2015, selling an estimated $8.26K and leaving 10,671 shares worth $376K. The position accounts for ﹤0.01% of the portfolio, ranked #1041.

Baird first reported a position in BRLI in Q2 2013 and has held it in 8 quarters since. The position peaked at $820K in Q1 2014. 168 funds tracked by Wall St. Rank hold BRLI as of Q1 2015.

  • Baird held 10,671 shares of BIO-REFERENCE LABS INC-NEW- worth $376K as of Q1 2015.
  • Baird sold 244 BIO-REFERENCE LABS INC-NEW- shares in Q1 2015, an estimated $8.26K.
  • BIO-REFERENCE LABS INC-NEW- made up ﹤0.01% of Baird's portfolio in Q1 2015, its #1041 holding.
  • Baird first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and has held it in 8 quarters since.
  • Baird's BIO-REFERENCE LABS INC-NEW- position peaked at $820K in Q1 2014.
  • 168 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.